Dexcom reported higher profit and revenue in the second quarter as demand for its continuous glucose monitors grew in the U.S. and internationally.

The diabetes-device maker reported a profit of $249.1 million, or 64 cents a share, compared with a profit of $179.8 million, or 45 cents a share, a year earlier.

Adjusted earnings were 70 cents a share, compared with analysts' expectations of 61 cents a share, according to FactSet.

Revenue rose 13% to $1.31 billion. Analysts polled by FactSet expected $1.29 billion.

Dexcom said U.S. revenue rose 11% and international revenue rose 19% year over year.

For the full year, the company expects revenue of $5.18 billion to $5.25 billion, up from $5.16 billion to $5.25 billion previously.